SCHEMBL13049754

SCHEMBL13049754

CC(=O)C(NC(=O)O)C(C)C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.38
ALDH1A1 P00352 3/20 0.38
NPSR1 Q6W5P4 1/20 0.34
CYP2D6 P10635 1/20 0.33
CYP2C19 P33261 1/20 0.33
LMNA P02545 1/20 0.32
GAA P10253 1/20 0.32
HPGD P15428 1/20 0.32
PLA2G2A P14555 1/20 0.32
PLA2G5 P39877 1/20 0.32
RAB9A P51151 1/20 0.32
CA12 O43570 1/20 0.32
CA14 Q9ULX7 1/20 0.32
DPP4 P27487 1/20 0.32
DPP8 Q6V1X1 1/20 0.32
DPP9 Q86TI2 1/20 0.32
KMT2A Q03164 1/20 0.32
KDM4E B2RXH2 1/20 0.32
FPR2 P25090 1/20 0.32
TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13018857 0.81 DPP4 (0.43) SMN1; SMN2ALDH1A1NPSR1CA12CA14
SCHEMBL8130071 0.81 DPP4 (0.43) SMN1; SMN2ALDH1A1NPSR1CA12CA14
SCHEMBL9717667 0.81 SMN1; SMN2 (0.48) SMN1; SMN2ALDH1A1NPSR1LMNAGAA
SCHEMBL15368410 0.81 DPP4 (0.43) SMN1; SMN2ALDH1A1NPSR1CA12CA14
SCHEMBL14389451 0.81 SMN1; SMN2 (0.48) SMN1; SMN2ALDH1A1NPSR1LMNAGAA
SCHEMBL8752641 0.81 SMN1; SMN2 (0.48) SMN1; SMN2ALDH1A1NPSR1LMNAGAA
SCHEMBL1496401 0.79 ALDH1A1 (0.34) SMN1; SMN2ALDH1A1NPSR1CYP2D6CYP2C19
SCHEMBL13049755 0.79 ALDH1A1 (0.34) SMN1; SMN2ALDH1A1NPSR1CYP2D6CYP2C19
SCHEMBL13530960 0.78 ALDH1A1 (0.56) SMN1; SMN2ALDH1A1NPSR1LMNAGAA
SCHEMBL23201575 0.77 SMN1; SMN2 (0.33) SMN1; SMN2ALDH1A1NPSR1CYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010138791-A1 ANTIVIRAL COMPOUNDS COMPOSED OF THREE LINKED ARYL MOIETIES TO TREAT DISEASES SUCH AS HEPATITIS C SCHERING CORPORATION (US) 2010-12-02 WO disclosed